GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (FRA:NB3) » Definitions » Purchase Of Property, Plant, Equipment

Neurocrine Biosciences (FRA:NB3) Purchase Of Property, Plant, Equipment : €-35 Mil (TTM As of Dec. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Neurocrine Biosciences Purchase Of Property, Plant, Equipment?

Neurocrine Biosciences's purchase of property, plant, equipment for the three months ended in Dec. 2024 was €-7 Mil. It means Neurocrine Biosciences spent €7 Mil on purchasing property, plant, equipment. Neurocrine Biosciences's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2024 was €-35Mil.

Compared with last quarter (€-7 Mil in Sep. 2024 ), Neurocrine Biosciences spent less money on purchasing property, plant, equipment in Dec. 2024 (€-7 Mil).


Neurocrine Biosciences Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Neurocrine Biosciences's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences Purchase Of Property, Plant, Equipment Chart

Neurocrine Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Property, Plant, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.96 -20.71 -15.58 -25.95 -36.48

Neurocrine Biosciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Purchase Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.95 -10.30 -10.78 -7.30 -6.97

Neurocrine Biosciences Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurocrine Biosciences Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Neurocrine Biosciences's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurocrine Biosciences Business Description

Industry
Traded in Other Exchanges
Address
6027 Edgewood Bend Court, San Diego, CA, USA, 92130
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Neurocrine Biosciences Headlines

No Headlines